First Time Loading...
C

Charmacy Pharmaceutical Co Ltd
HKEX:2289

Watchlist Manager
Charmacy Pharmaceutical Co Ltd
HKEX:2289
Watchlist
Price: 14 HKD Market Closed
Updated: May 21, 2024

Charmacy Pharmaceutical Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Charmacy Pharmaceutical Co Ltd
Operating Income Peer Comparison

Comparables:
1099
601607
600998
C
600511
000963

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
C
Charmacy Pharmaceutical Co Ltd
HKEX:2289
Operating Income
¥107.5m
CAGR 3-Years
11%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Sinopharm Group Co Ltd
HKEX:1099
Operating Income
¥22.3B
CAGR 3-Years
5%
CAGR 5-Years
7%
CAGR 10-Years
14%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Operating Income
¥8.5B
CAGR 3-Years
-1%
CAGR 5-Years
8%
CAGR 10-Years
11%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Operating Income
¥4.1B
CAGR 3-Years
1%
CAGR 5-Years
8%
CAGR 10-Years
17%
C
China National Medicines Corp Ltd
SSE:600511
Operating Income
¥2.5B
CAGR 3-Years
13%
CAGR 5-Years
5%
CAGR 10-Years
20%
Huadong Medicine Co Ltd
SZSE:000963
Operating Income
¥3.8B
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
14%

See Also

What is Charmacy Pharmaceutical Co Ltd's Operating Income?
Operating Income
107.5m CNY

Based on the financial report for Dec 31, 2023, Charmacy Pharmaceutical Co Ltd's Operating Income amounts to 107.5m CNY.

What is Charmacy Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
4%

Over the last year, the Operating Income growth was 19%. The average annual Operating Income growth rates for Charmacy Pharmaceutical Co Ltd have been 11% over the past three years , 4% over the past five years .